1. Kyorin Pharmaceutical. Beova Tablets 50 mg: Japanese prescribing information. 2018.
http://www.info.pmda.go.jp/downfiles/ph/PDF/230109_25900A7F1025_1_02.pdf
. Accessed 3 Oct 2018.
2. Kyorin Pharmaceutical. Kyorin and Kissei signed an agreement for co-development and co-marketing of KRP-114V [media release]. 30 Mar 2016.
3. Roivant Sciences. Roivant Sciences launches Urovant to develop innovative therapies in urology [media release]. 6 Jun 2017.
4. Di Salvo J, Nagabukuro H, Wickham LA, et al. Pharmacological characterization of a novel beta 3 adrenergic agonist, vibegron: evaluation of antimuscarinic receptor selectivity for combination therapy for overactive bladder. J Pharmacol Exp Ther. 2017;360(2):346–55.
5. Urovant Sciences. Pipeline. 2018.
https://urovant.com/pipeline/
. Accessed 24 Oct 2018.